187 related articles for article (PubMed ID: 30768851)
1. Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP
Li T; Stephen P; Zhu DW; Shi R; Lin SX
FEBS J; 2019 Jun; 286(11):2155-2166. PubMed ID: 30768851
[TBL] [Abstract][Full Text] [Related]
2. New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1.
Li T; Song X; Stephen P; Yin H; Lin SX
J Steroid Biochem Mol Biol; 2023 Apr; 228():106246. PubMed ID: 36634828
[TBL] [Abstract][Full Text] [Related]
3. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors.
Breton R; Housset D; Mazza C; Fontecilla-Camps JC
Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577
[TBL] [Abstract][Full Text] [Related]
4. Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.
Sawicki MW; Erman M; Puranen T; Vihko P; Ghosh D
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):840-5. PubMed ID: 9927655
[TBL] [Abstract][Full Text] [Related]
5. Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase.
Mazza C; Breton R; Housset D; Fontecilla-Camps JC
J Biol Chem; 1998 Apr; 273(14):8145-52. PubMed ID: 9525918
[TBL] [Abstract][Full Text] [Related]
6. Two non-reactive ternary complexes of estrogenic 17beta-hydroxysteroid dehydrogenase: crystallization and preliminary structural analysis.
Qiu W; Zhu DW; Azzi A; Campbell RL; Qi H; Poirier D; Lin SX
J Steroid Biochem Mol Biol; 1999 Mar; 68(5-6):239-44. PubMed ID: 10416839
[TBL] [Abstract][Full Text] [Related]
7. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.
Gangloff A; Garneau A; Huang YW; Yang F; Lin SX
Biochem J; 2001 May; 356(Pt 1):269-76. PubMed ID: 11336660
[TBL] [Abstract][Full Text] [Related]
8. Insights in 17beta-HSD1 enzyme kinetics and ligand binding by dynamic motion investigation.
Negri M; Recanatini M; Hartmann RW
PLoS One; 2010 Aug; 5(8):e12026. PubMed ID: 20706575
[TBL] [Abstract][Full Text] [Related]
9. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
Han H; Thériault JF; Chen G; Lin SX
J Steroid Biochem Mol Biol; 2017 Sep; 172():36-45. PubMed ID: 28554725
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17beta-hydroxysteroid dehydrogenase 1.
Ghosh D; Vihko P
Chem Biol Interact; 2001 Jan; 130-132(1-3):637-50. PubMed ID: 11306082
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validation.
Klein T; Henn C; Negri M; Frotscher M
PLoS One; 2011; 6(8):e22990. PubMed ID: 21857977
[TBL] [Abstract][Full Text] [Related]
12. Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone.
Ngueta AD; Roy J; Maltais R; Poirier D
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677690
[TBL] [Abstract][Full Text] [Related]
13. Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation.
Shi R; Lin SX
J Biol Chem; 2004 Apr; 279(16):16778-85. PubMed ID: 14966133
[TBL] [Abstract][Full Text] [Related]
14. Secretory expression, purification and functional characterization of 17β-hydroxysteroid dehydrogenase type 1 from mammalian HEK293T cells.
Chen J; Feng W; Zhao Y
Protein Expr Purif; 2017 Sep; 137():52-57. PubMed ID: 28669870
[TBL] [Abstract][Full Text] [Related]
15. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women.
Luu-The V; Tremblay P; Labrie F
Mol Endocrinol; 2006 Feb; 20(2):437-43. PubMed ID: 16166196
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives.
Fournier D; Poirier D; Mazumdar M; Lin SX
Eur J Med Chem; 2008 Nov; 43(11):2298-306. PubMed ID: 18372081
[TBL] [Abstract][Full Text] [Related]
17. Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy.
Mazumdar M; Fournier D; Zhu DW; Cadot C; Poirier D; Lin SX
Biochem J; 2009 Dec; 424(3):357-66. PubMed ID: 19929851
[TBL] [Abstract][Full Text] [Related]
18. Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Messinger J; Husen B; Koskimies P; Hirvelä L; Kallio L; Saarenketo P; Thole H
Mol Cell Endocrinol; 2009 Mar; 301(1-2):216-24. PubMed ID: 19014997
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore modelling of 17beta-HSD1 enzyme based on active inhibitors and enzyme structure.
Karkola S; Alho-Richmond S; Wahala K
Mol Cell Endocrinol; 2009 Mar; 301(1-2):225-8. PubMed ID: 18822344
[TBL] [Abstract][Full Text] [Related]
20. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH.
Jin JZ; Lin SX
Biochem Biophys Res Commun; 1999 Jun; 259(2):489-93. PubMed ID: 10362535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
